Nemaura Medical Inc.
NMRD
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 3.00K | 77.00K | 77.00K | 397.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 3.00K | 77.00K | 77.00K | 397.30K |
| Cost of Revenue | 1.48M | 1.48M | 1.55M | 1.55M | 247.30K |
| Gross Profit | -1.48M | -1.48M | -1.48M | -1.48M | 150.10K |
| SG&A Expenses | 5.59M | 5.57M | 5.38M | 5.14M | 5.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.96M | 9.04M | 8.69M | 8.23M | 7.69M |
| Operating Income | -8.96M | -9.04M | -8.61M | -8.15M | -7.29M |
| Income Before Tax | -10.65M | -10.21M | -12.86M | -14.14M | -13.43M |
| Income Tax Expenses | -- | -- | -- | -- | -350.30K |
| Earnings from Continuing Operations | -10.65 | -10.21 | -12.86 | -14.14 | -13.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.65M | -10.21M | -12.86M | -14.14M | -13.08M |
| EBIT | -8.96M | -9.04M | -8.61M | -8.15M | -7.29M |
| EBITDA | -8.47M | -8.54M | -8.17M | -7.71M | -6.93M |
| EPS Basic | -0.38 | -0.38 | -0.49 | -0.56 | -0.54 |
| Normalized Basic EPS | -0.21 | -0.21 | -0.29 | -0.33 | -0.35 |
| EPS Diluted | -0.39 | -0.38 | -0.49 | -0.56 | -0.54 |
| Normalized Diluted EPS | -0.21 | -0.21 | -0.29 | -0.33 | -0.35 |
| Average Basic Shares Outstanding | 113.90M | 109.11M | 104.31M | 99.51M | 96.11M |
| Average Diluted Shares Outstanding | 113.90M | 109.11M | 104.31M | 99.51M | 96.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |